Clinical Trial Update: VSL#3 and Spontaneous Bacterial Peritonitis [Phase 2]

View source ↗

Summary

Phase 2 trial of VSL#3 for prevention or treatment of spontaneous bacterial peritonitis in patients with decompensated cirrhosis and ascites was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Liver Cirrhosis
• Spontaneous Bacterial Peritonitis

Drugs mentioned

• VSL#3

Snippet

Sponsor: Nottingham University Hospitals NHS Trust | Conditions: Decompensated Cirrhosis, Ascites | Phase 2 | Status: TERMINATED